BIOTECH AUSTRIA

A good valuation is only part of a good VC deal. What about control? For biotech start-ups and scale-ups, negotiating a term sheet can shape much more than the next financing round. It can determine who makes which decisions, how future value is shared and how much room founders retain to steer their company.   At the BIOTECH SUMMIT AUSTRIA 2026, Phillip Dubsky and Sonja Hebenstreit (Herbst Kinsky Rechtsanwälte), together with Joachim Vogt from AbbVie Ventures, will take participants right into the negotiation room in the hands-on workshop:   🔸 “Mastering the Term Sheet: How to Negotiate Value and Control with VCs” 🔸 The workshop will deconstruct a standard VC term sheet, highlight potential pitfalls and put negotiation strategies to the test. Because the Biotech Summit is not only about hearing from leading experts. Our interactive workshops create space to ask questions, challenge assumptions and work through real-world scenarios together. 📍 Innsbruck 📅 13–14 October 2026 Ready to negotiate a founder-friendly deal without scaring off the investors? #add this one or one of the other two workshop now! Already registered? Log in on the website and click “Add” in the Hashtag #agenda to secure your place in your preferred Hashtag #workshop. The same applies to the Health Hub Tour and scheduling your 1:1 meetings. The BIOTECH SUMMIT AUSTRIA is a joint initiative of BIOTECH AUSTRIA, Human.technology Styria GmbH, and Health Hub Tirol / Standortagentur Tirol.   #BSA26 #BiotechSummitAustria #VentureCapital #Biotech #Startups #LifeSciences

Yesterday’s BIOTECH AUSTRIA Policy & Strategy Community Call brought together a large number of members, underlining the strong commitment of Austria’s biotech community to shaping the future of our industry. The session highlighted our current policy activities, strategic priorities, and the collective efforts underway to strengthen Austria as a leading biotech location. A special thank you to our Policy Group and Working Group Heads for sharing the progress and priorities of their teams: 👉 Capital (Access to Capital) Thomas Moser | Advancing measures to attract more biotech investment and strengthen funding opportunities for innovative companies. 👉 Infrastructure (Expanding Biotech Infrastructure) Klaus Graumann | Driving initiatives to expand laboratory capacity, core facilities, and biotech clusters across Austria. 👉 Research & Transfer (Improving Research Translation) Simona Neubauer-Gstrein MBA | Supporting stronger innovation funding, faster research translation, and the creation of successful spin-offs. 👉 EU Policy (Shaping EU Framework for Austrian Biotechs) Olivier Jankowitsch | Ensuring Austrian biotech interests are represented in key European initiatives, including the EU Biotech Act. As our President Peter Llewellyn-Davies concluded: Austria has outstanding biotech potential. By working together on key areas like capital, infrastructure, research translation and regulation, we can accelerate innovation, attract investment, and create sustainable high-value jobs. Thank you to everyone who joined the discussion and contributes to making Austria’s biotech ecosystem stronger every day. 🚀🧬 #BiotechAustria #Biotechnology #LifeSciences #Innovation #HealthTech #Research #Investment #EUPolicy #AustriaBiotech #StrongerTogether

Does Europe need its own venture capital playbook? Silicon Valley has shaped the global VC model for decades. But does Europe really need to copy it – or is it time to define its own identity for venture capital? At the BIOTECH SUMMIT AUSTRIA 2026, Stefan Haubner will explore exactly this question in his keynote: 🔸 “Beyond the Silicon Valley Playbook: In Search of a European Identity for Venture Capital” 🔸 As Founding Partner at APEX Ventures, board member of invest.austria, COO at Othis Technology and member of the VC Council of Invest Europe, Stefan brings the perspective of an investor, entrepreneur and founder deeply rooted in the Austrian and European startup ecosystem. A timely discussion about capital, ambition and what Europe needs to turn innovation into globally successful companies. 📍 Innsbruck 📅 13–14 October 2026 The BIOTECH SUMMIT AUSTRIA is a joint initiative of BIOTECH AUSTRIA, Human.technology Styria GmbH and Health Hub Tirol / Standortagentur Tirol. #BiotechSummitAustria #BSA2026 #VentureCapital #Biotech #LifeSciences #Startups #Investment #EuropeanInnovation

The countdown is on – and the BIOTECH SUMMIT AUSTRIA is filling up fast! 🚀 With less than a month to go, the momentum is building – and so is the excitement for two inspiring days in Innsbruck. The Bergisel Experience is already SOLD OUT, the Dinner & Party is almost fully booked, and only a few conference tickets and exhibition spots remain. If the BIOTECH SUMMIT AUSTRIA is on your agenda this year, now is the time to secure your place. Look forward to a high-level programme with outstanding speakers, fresh perspectives from science, industry and politics, targeted 1:1 partnering and plenty of opportunities to connect with decision-makers, innovators, investors and biotech leaders from Austria and beyond. #add now! Already registered? Log in on the website and click “Add” in the #agenda to secure your place in your preferred #workshop. The same applies to the Health Hub Tour and scheduling your 1:1 meetings. 13–14 October 2026 | Innsbruck, Austria Don’t miss your chance to be part of it: 👉 https://lnkd.in/edhxKY8W Organised by BIOTECH AUSTRIA, Human.technology Styria GmbH and Health Hub Tirol / Standortagentur Tirol. Start up, Scale up … Step up! #BSA26 #BiotechSummitAustria #Biotech #LifeSciences #Biotechnology #Innovation #Networking #Innsbruck #Austria

Netzwerken im Heurigen - wieder ein gelungener Abend! Auch dieses Jahr durften wir bei unserem traditionellen Heurigen-Abend wieder Mitglieder und Partner aus der österreichischen Biotech-Community begrüßen. Bei gutem Essen, kühlen Getränken und in entspannter Atmosphäre stand vor allem eines im Mittelpunkt: der persönliche Austausch. Es war schön, bekannte Gesichter wiederzusehen, neue Kontakte zu knüpfen und sich über aktuelle Themen, Projekte und die Entwicklungen in der Branche auszutauschen. Vielen Dank an alle, die dabei waren und diesen Abend zu einem so schönen und geselligen Get-together gemacht haben! Wir freuen uns schon auf das nächste Mal. #BIOTECHAUSTRIA #Networking #Biotech #LifeSciences

💡 Great ideas may start on stage – but great collaborations often start with a conversation. From September 14, B2B meetings for the BIOTECH SUMMIT AUSTRIA 2026 are open for booking! 🤝 Browse the participant list, connect with the people you want to meet and schedule your 1:1 conversations in Innsbruck. 👉 Don’t wait too long – the best slots fill up fast. 📍 October 13–14, 2026 | Innsbruck 🌐 https://lnkd.in/edhxKY8W The BIOTECH SUMMIT AUSTRIA is jointly organized by BIOTECH AUSTRIA, Human.technology Styria GmbH and Health Hub Tirol / Standortagentur Tirol. #BSA26 #Biotech #Networking #LifeSciences #B2B

Autumn has arrived – and the wind is picking up. Perfect timing for our next #BSA26 agenda highlight! ⛵ “Weathering the Biotech Storms – Stepping Up to Master the Stormy Rides!” Olympic sailing champion Lukas Mähr knows a thing or two about keeping course when conditions get rough. In his keynote, he will share what biotech can learn from elite sailing about resilience, teamwork and peak performance – especially when the waters get choppy. 📍 BIOTECH SUMMIT AUSTRIA | Innsbruck 📅 13-14 October 2026 Ready to weather the storm with us? 👉 https://lnkd.in/edhxKY8W The BIOTECH SUMMIT AUSTRIA is a joint initiative of BIOTECH AUSTRIA, Human.technology Styria GmbH and Health Hub Tirol / Standortagentur Tirol. #BSA26 #Biotech #Leadership #Resilience #Teamwork Porträt © Frederick Sams / sams-foto.com Segelbild Medal Race © Sailing Energy Segelbild 2 © Dominik Matesa

❣️ Want to put your company in the spotlight at #BSA26? ❣️ A few sponsorship opportunities are still available for the BIOTECH SUMMIT AUSTRIA 2026. Present your company to a highly relevant biotech and life sciences community, connect with decision-makers and innovators, and become part of one of Austria’s key industry gatherings. Our Contribution Packages include: 👉 showcasing your company in the Exhibition Area 👉 networking with the biotech community throughout the summit 👉 increased visibility with your logo on the BSA website and various digital and print materials 👉 the opportunity to present your company on stage (depending on the package) Secure one of the remaining sponsorship spots and join us in Innsbruck! 🌐 https://lnkd.in/edhxKY8W #BiotechSummitAustria #BSA26 #Biotech #LifeSciences #Sponsoring #Networking #Exhiition #Contribution The BIOTECH SUMMIT AUSTRIA is a joint initiative of BIOTECH AUSTRIA, Human.technology Styria GmbH, and Health Hub Tirol / Standortagentur Tirol.

✨ How do you turn breakthrough science into sustainable growth? ✨ Scaling a biotech company takes more than great science. It requires the right combination of leadership, organisational development and a business model that can evolve along the way. At the BIOTECH SUMMIT AUSTRIA 2026, Dr. Antonius Greiner (Heitger+ by KPMG), Nina Sattlegger (Talentor Austria) and Michael Klewan (KPMG Austria) will lead the interactive workshop: “Scaling Biotech: Leading Change from Discovery to Sustainable Growth” Together with participants, they will explore what it takes to build organisations that can grow, adapt and create lasting value without losing the innovative DNA that made them successful in the first place. Workshops like this add another dimension to the Biotech Summit: less listening, more exchange and the opportunity to discuss real-life challenges directly with experts and peers. 📍 Innsbruck 📅 13-14 October 2026 We look forward to a lively discussion with founders, biotech leaders and experts from across the ecosystem. The BIOTECH SUMMIT AUSTRIA is a joint initiative of BIOTECH AUSTRIA, Human.technology Styria GmbH, and Health Hub Tirol / Standortagentur Tirol. #BSA26 #BiotechSummitAustria #Biotech #ScalingUp #Leadership #LifeSciences

👉 "Patents in Motion - Global IP Strategy for Dynamic Markets"    This workshop will examine how patent strategy must adapt to a world shaped by rapid technological change, evolving markets and rising investor expectations. We will discuss key questions such as where to file, what level of supporting data is needed in different fields (such as therapeutics versus medical devices), how to approach AI inventions and how to build a patent portfolio that not only protects innovation but also strengthens a company’s investment story. The session will offer practical perspectives on aligning IP strategy with commercial priorities in a fast-changing global landscape. Dr. Annelie Wünsche, Partner, and Alexander Feil, Patent Attorney, both Maiwald Intellectual Property, will lead the workshop and illustrate the topics with numerous practical examples. ℹ️ Advance registration for the workshop is required – opening soon! 📅 Tuesday, 13 October 2026 📍 Villa Blanka, Innsbruck 🌐 https://lnkd.in/e8zeY_Nx   The BIOTECH SUMMIT AUSTRIA is a joint initiative of BIOTECH AUSTRIA, Human.technology Styria GmbH, and Health Hub Tirol / Standortagentur Tirol. #BSA26 #Workshop #Patents